Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NARI - Inari Medical, Inc.


IEX Last Trade
53.605
9.215   17.191%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:18:42 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%

$44.39
9.22
20.76%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
12%
Profitability 2%
Dept financing 13%
Liquidity 59%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
-3.25%
1 Month
8.43%
3 Months
29.34%
6 Months
17.22%
1 Year
-18.35%
2 Year
-14.49%
Key data
Stock price
$53.60
P/E Ratio 
-44.15
DAY RANGE
$44.39 - $53.01
EPS 
-$0.99
52 WEEK RANGE
$38.36 - $66.61
52 WEEK CHANGE
-$18.47
MARKET CAP 
2.519 B
YIELD 
N/A
SHARES OUTSTANDING 
58.267 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/30/2024
BETA 
0.48
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,207,989
AVERAGE 30 VOLUME 
$1,137,266
Company detail
CEO: William H. Hoffman
Region: US
Website: inarimedical.com
Employees: 800
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Inari Medical, Inc. develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels. FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.

Recent news